Martina Geiger

Title: Martina Geiger: Innovator in Antibody Activity and T-Cell Therapy

Introduction

Martina Geiger is a prominent inventor based in Obfelden, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of methods for determining antibody activity in tumor samples and advancements in adoptive T-cell therapy. With a total of 3 patents, her work is paving the way for innovative treatments in cancer therapy.

Latest Patents

Martina's latest patents include groundbreaking inventions such as methods to determine antibody activity in tumor samples. This invention relates to a new cell-based assay that allows for the robust determination of antigen and protease expression in primary tumor samples without the need to digest them. This method facilitates the selection of antibodies and protease-cleavable linkers for tumor treatment. Another significant patent focuses on adoptive T-cell therapy, which involves T-cells transfected with a fusion protein that interacts with a trivalent, bispecific antibody molecule. This invention includes a kit comprising nucleic acid molecules, vectors, and fusion proteins, as well as methods for treating specific diseases using these innovative therapies.

Career Highlights

Throughout her career, Martina has worked with notable companies, including Hoffmann-La Roche Inc. Her experience in the biotechnology sector has allowed her to develop and refine her inventions, contributing to advancements in cancer treatment.

Collaborations

Martina has collaborated with esteemed colleagues such as Christian Klein and Claudio Sustmann. These partnerships have further enhanced her research and development efforts in the field of biotechnology.

Conclusion

Martina Geiger's innovative work in antibody activity determination and T-cell therapy exemplifies her commitment to advancing medical science. Her contributions are vital in the ongoing fight against cancer, showcasing the importance of innovation in healthcare.